Baku 28° C
BioNTech, Pfizer studying new COVID variant
Health
- 26 November, 2021
- 13:30
BioNTech and Pfizer said that experts are studying a new variant of coronavirus discovered in South Africa, more information is expected in two weeks, Report informs.
“We expect more laboratory data in two weeks at the latest,” BioNTech spokesman said, according to Agence France-Presse.
The company stressed that the data will help to understand whether the variant of coronavirus B.1.1.529 could “require a vaccine adjustment” by Pfizer/BioNTech in the event that it spreads worldwide.
Author
Latest News
16:26
LMAC: Conflict in southern Lebanon affects demining operations
Foreign policy16:04
Israel plans to return five Lebanese prisoners today
Other countries15:53
Jaishankar: Russia-Ukraine war will not be resolved by buying or rejecting oil
Other countries15:48
Azerbaijan resumes bee imports from Uzbekistan
Business15:34
Dispute over Morocco's role in Ceuta migration crisis intensifies in Spain
Other countries15:27
Photo
Jeyhun Bayramov discusses Baku-Yerevan peace agenda with OSCE PA President
Foreign policy15:21
Anar Guliyev: Mine clearance - integral part of territorial planning
Infrastructure15:02
Azerbaijan creates unified cybersecurity platform
ICT14:55